Acceleron Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch XLRN and buy or sell other stocks, ETFs, and their options commission-free!About XLRN
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension.
CEOHabib J. Dable, MBA
CEOHabib J. Dable, MBA
Employees—
Employees—
HeadquartersRahway, New Jersey
HeadquartersRahway, New Jersey
Founded2003
Founded2003
Employees—
Employees—
XLRN Key Statistics
Market cap10.93B
Market cap10.93B
Price-Earnings ratio-42.53
Price-Earnings ratio-42.53
Dividend yield—
Dividend yield—
Average volume1.94M
Average volume1.94M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$189.99
52 Week high$189.99
52 Week low$111.29
52 Week low$111.29
Stock Snapshot
Acceleron Pharma(XLRN) stock is priced at $178.75, giving the company a market capitalization of 10.93B. It carries a P/E multiple of -42.53.
On 2026-01-02, Acceleron Pharma(XLRN) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Acceleron Pharma(XLRN) stock has reached 0, versus its average volume of 1.94M.
Over the past 52 weeks, Acceleron Pharma(XLRN) stock has traded between a high of $189.99 and a low of $111.29.
Over the past 52 weeks, Acceleron Pharma(XLRN) stock has traded between a high of $189.99 and a low of $111.29.
People also own
Based on the portfolios of people who own XLRN. This list is generated using Robinhood data, and it’s not a recommendation.